Clinical Trial

Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the absorption, metabolism and excretion after a single intravenous bolus of \[14C\]HRS-9190 in healthy Participants
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-04-25
notable Primary completion pushed: 2026-04 -> 2026-05 2026-04-25
minor Completion pushed: 2026-04 -> 2026-05 2026-04-25
Trial Details
NCT Number NCT07494175
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Healthy Adult Male
Enrollment 6 participants
Start Date 2026-04-11
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-24